Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
Recruiting
Observational Study
HPV Infection
Cervical Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 50 (estimated)
- Sponsor
- University Hospital Tuebingen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a prospective, single-center, observational proof-of-principle clinical trial at the Department of Women's Health of the University Hospital Tübingen.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Inclusion criteria for NIPP treatment
* Age ≥ 18 years
* mRNA or DNA-based virus detection by smear (also external findings)
* Clearly visible transformation zone of the cervix and margins of the lesions corresponding to T1/T2
* Written informed consent to participate…
Contacts